Eric T. Rush

1.9k total citations
51 papers, 815 citations indexed

About

Eric T. Rush is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Eric T. Rush has authored 51 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Eric T. Rush's work include Alkaline Phosphatase Research Studies (16 papers), Connective tissue disorders research (11 papers) and Heterotopic Ossification and Related Conditions (10 papers). Eric T. Rush is often cited by papers focused on Alkaline Phosphatase Research Studies (16 papers), Connective tissue disorders research (11 papers) and Heterotopic Ossification and Related Conditions (10 papers). Eric T. Rush collaborates with scholars based in United States, Canada and France. Eric T. Rush's co-authors include William B. Rizzo, Nancy Braverman, Anna Petryk, Ann B. Moser, Steven J. Steinberg, Mousumi Bose, Joseph G. Hacia, Gerald V. Raymond, Edwin M. Stone and Michael F. Wangler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Eric T. Rush

46 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric T. Rush United States 13 386 241 218 181 126 51 815
Taichi Kitaoka Japan 16 273 0.7× 349 1.4× 254 1.2× 201 1.1× 93 0.7× 49 798
Jair Tenorio Spain 18 344 0.9× 329 1.4× 113 0.5× 161 0.9× 65 0.5× 76 943
Simona Borsari Italy 19 224 0.6× 469 1.9× 208 1.0× 96 0.5× 131 1.0× 56 1.3k
Chun‐Ming Pan China 16 656 1.7× 195 0.8× 176 0.8× 27 0.1× 60 0.5× 33 1.1k
Junko Tsubaki Japan 11 371 1.0× 234 1.0× 386 1.8× 24 0.1× 81 0.6× 17 894
Akie Nakamura Japan 19 524 1.4× 532 2.2× 236 1.1× 40 0.2× 123 1.0× 77 952
Rivka Dresner Pollak Israel 13 201 0.5× 173 0.7× 23 0.1× 85 0.5× 126 1.0× 15 685
Sarah J. Rice United Kingdom 18 403 1.0× 199 0.8× 31 0.1× 449 2.5× 61 0.5× 36 1.0k
Rune Jemtland Norway 17 560 1.5× 81 0.3× 101 0.5× 89 0.5× 82 0.7× 28 918
Jona Saemundsdottir Iceland 4 504 1.3× 322 1.3× 68 0.3× 82 0.5× 39 0.3× 4 757

Countries citing papers authored by Eric T. Rush

Since Specialization
Citations

This map shows the geographic impact of Eric T. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric T. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric T. Rush more than expected).

Fields of papers citing papers by Eric T. Rush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric T. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric T. Rush. The network helps show where Eric T. Rush may publish in the future.

Co-authorship network of co-authors of Eric T. Rush

This figure shows the co-authorship network connecting the top 25 collaborators of Eric T. Rush. A scholar is included among the top collaborators of Eric T. Rush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric T. Rush. Eric T. Rush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Aliya, et al.. (2025). Key Learnings from Clinical Research and Real-World Evidence on Asfotase Alfa Effectiveness in Hypophosphatasia: 10 Years Post-Approval. Advances in Therapy. 42(9). 4270–4299. 1 indexed citations
2.
Kishnani, Priya S., Catherine Rehder, Keiichi Ozono, et al.. (2025). Revisiting the Genetics of Hypophosphatasia. Journal of Inherited Metabolic Disease. 48(6). e70083–e70083.
3.
Kishnani, Priya S., Lothar Seefried, Keiichi Ozono, et al.. (2025). The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data. Orphanet Journal of Rare Diseases. 20(1). 626–626.
4.
Rehder, Catherine, Gerald Webersinke, Cheryl R. Greenberg, et al.. (2025). Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants. Journal of Bone and Mineral Research. 41(3). 259–269. 1 indexed citations
5.
Seefried, Lothar, Franca Genest, Christine Hofmann, Maria Luisa Brandi, & Eric T. Rush. (2025). Diagnosis and Treatment of Hypophosphatasia. Calcified Tissue International. 116(1). 46–46. 4 indexed citations
6.
Rush, Eric T., et al.. (2025). Genetic characterization of a large cohort of individuals with a clinical suspicion of hypophosphatasia in the United States. Molecular Genetics and Metabolism. 144(3). 109046–109046. 2 indexed citations
7.
Dahir, Kathryn, et al.. (2024). A Delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United States. Journal of Endocrinological Investigation. 47(6). 1487–1497. 3 indexed citations
8.
Rehder, Catherine, Cheryl R. Greenberg, Kathryn Dahir, et al.. (2023). The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone. 178. 116947–116947. 26 indexed citations
9.
Rush, Eric T., Lillian Shum, Anna Teti, et al.. (2021). Proceedings of the 2020 Rare Bone Disease Working Group. JBMR Plus. 5(S1).
10.
Kishnani, Priya S., et al.. (2021). Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa. Molecular Genetics and Metabolism. 133(1). 113–121. 10 indexed citations
11.
Lewiecki, E. Michael, John P. Bilezikian, Risa Kagan, et al.. (2019). Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases. Journal of Clinical Densitometry. 23(1). 1–20. 9 indexed citations
12.
13.
Wu, Calvin C., Michael J. Econs, Linda A. DiMeglio, et al.. (2017). Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group. The Journal of Clinical Endocrinology & Metabolism. 102(9). 3111–3123. 138 indexed citations
14.
Rush, Eric T., et al.. (2016). Echocardiographic phenotype in osteogenesis imperfecta varies with disease severity. Heart. 103(6). 443–448. 11 indexed citations
15.
Newton, Laura, Shahab Abdessalam, Stephen C. Raynor, et al.. (2016). Neurodevelopmental outcomes of tracheoesophageal fistulas. Journal of Pediatric Surgery. 51(5). 743–747. 7 indexed citations
16.
Azzam, Khalid, et al.. (2016). Mid-term Results of Femoral and Tibial Osteotomies and Fassier-Duval Nailing in Children With Osteogenesis Imperfecta. Journal of Pediatric Orthopaedics. 38(6). 331–336. 46 indexed citations
17.
Rush, Eric T., et al.. (2015). Low bone mineral density is a common feature of Zellweger spectrum disorders. Molecular Genetics and Metabolism. 117(1). 33–37. 13 indexed citations
18.
Braverman, Nancy, Gerald V. Raymond, William B. Rizzo, et al.. (2015). Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. Molecular Genetics and Metabolism. 117(3). 313–321. 177 indexed citations
19.
Rush, Eric T., Margaret P Adam, Robin D. Clark, et al.. (2013). Four new patients with Gomez–Lopez‐Hernandez syndrome and proposed diagnostic criteria. American Journal of Medical Genetics Part A. 161(2). 320–326. 23 indexed citations
20.
Rush, Eric T. & G. Bradley Schaefer. (2010). Identification of an X-Linked Deletion Syndrome Through Comparative Genomic Hybridization Microarray. Seminars in Pediatric Neurology. 17(1). 51–53. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taichi Kitaoka Breakdown of academic impact, for papers by Jair Tenorio Breakdown of academic impact, for papers by Simona Borsari Breakdown of academic impact, for papers by Chun‐Ming Pan Breakdown of academic impact, for papers by Junko Tsubaki Breakdown of academic impact, for papers by Akie Nakamura Breakdown of academic impact, for papers by Rivka Dresner Pollak Breakdown of academic impact, for papers by Sarah J. Rice Breakdown of academic impact, for papers by Rune Jemtland Breakdown of academic impact, for papers by Jona Saemundsdottir
Rankless by CCL
2026